GTX INC /De
Memphis, US
Biotech
Founders & leadership
GA
Garry A. Neil, M.D.Director
HP
Henry P. DoggrellExecutive Officer
DC
Diane C. Young, M.D.Executive Officer
JK
J. Kenneth GlassDirector
JR
J. R. Hyde, IIIDirector
JT
Jason T. ShackelfordExecutive Officer
KS
Kenneth S. Robinson, M.D., M.Div.Director
MG
Michael G. Carter, M.D., Ch.B., F.R.C.P.Director
MS
Marc S. HanoverExecutive Officer, Director
RJ
Robert J. Wills, Ph.D.Executive Officer, Director
Reported raises · per SEC filings
Form D private placements$6.5MraisedDec 2020 · 4 investors · Biotechnology
Rule 506(b)$1.7MraisedNov 2020 · 4 investors · Biotechnology
Rule 506(b)$382.5KraisedSep 2020 · 4 investors · Biotechnology
Rule 506(b)$3.5MraisedAug 2020 · 12 investors · Biotechnology
Rule 506(b)$2.8MraisedJun 2020 · 7 investors · Biotechnology
Rule 506(b)$48.5MraisedOct 2017 · 8 investors · Biotechnology
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.